摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,6-Trimethyl-thionaphthen | 91144-23-9

中文名称
——
中文别名
——
英文名称
2,3,6-Trimethyl-thionaphthen
英文别名
2,3,6-Trimethyl-benzothiophene;2,3,6-trimethyl-1-benzothiophene
2,3,6-Trimethyl-thionaphthen化学式
CAS
91144-23-9
化学式
C11H12S
mdl
——
分子量
176.282
InChiKey
NETYMFPERAKHQJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    288.2±9.0 °C(Predicted)
  • 密度:
    1.089±0.06 g/cm3(Predicted)
  • 保留指数:
    1546.7

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    28.2
  • 氢给体数:
    0
  • 氢受体数:
    1

文献信息

  • DITHIENOBENZO-THIENO[3,2-B]THIOPHENE-COPOLYMER AND ITS USE AS HIGH PERFORMANCE SOLUTION PROCESSABLE SEMICONDUCTING POLYMER
    申请人:Kastler Marcel
    公开号:US20120289672A1
    公开(公告)日:2012-11-15
    Dithienobenzo-thieno[3,2-b]thiophene-copolymers of the formula (I) wherein: pi is a monocyclic or polycyclic moiety optionally substituted with 1-4 Ra groups, wherein R a , at each occurrence, is independently hydrogen or a) a halogen, b) —(CN, c) —NO 2 , d) oxo, e) —OH, f) ═C(R b ) 2 ; g) a C 1-20 alkyl group, h) a C 2-20 alkenyl group, i) a C 2-20 alkynyl group, j) a C 1-20 alkoxy group, k) a C 1-20 alkylthio group, l) a C 1-20 haloalkyl group, m) a —Y—C 3-10 cycloalkyl group, n) a —Y—C 6-14 aryl group, o) a —Y-3-12 membered cycloheteroalkyl group, or p) a —Y-5-14 membered heteroaryl group, wherein each of the C 1-20 alkyl group, the C 2-20 alkenyl group, the C 2-20 alkynyl group, the C 3-10 cycloalkyl group, the C 6-14 aryl or haloaryl group, the 3-12 membered cycloheteroalkyl group, and the 5-14 membered heteroaryl group is optionally substituted with 1-4 R b groups; Y, at each occurrence, is independently a divalent C 1-6 alkyl group, a divalent C 1-6 haloalkyl group, or a covalent bond; and R 1 , R 2 , R 3 , at each occurrence, are independently H, a halogen, CN, a C 1-30 alkyl group, a C 2-30 alkenyl group, a C 1-30 haloalkyl group, a C 2-30 alkynyl group, a C 1-30 alkoxy group, a C(O)—C 1-20 alkyl group, a C(O)—OC 1-20 alkyl group, a Y—C 3-10 cycloalkyl group, a —Y-3-12 membered cycloheteroalkyl group, each optionally substituted with 1-5 substituents selected from a halogen, —CN, a C 1-6 alkyl group, a C 1-6 alkoxy group, and a C 1-6 haloalkyl group, -L-Ar 1 , -L-Ar 1 -—Ar 1 , -L-Ar 1 —R 4 , or -L-Ar 1 —Ar 1 —R 4 and Y, at each occurrence, is independently a divalent C 1-6 alkyl group, a divalent C 1-6 haloalkyl group, or a covalent bond; n=0, 1, 2; and o=1-1000.
    公式(I)中的Dithienobenzo-thieno [3,2-b] thiophene共聚物,其中:pi是一个单环或多环基团,可选地取代1-4个Ra基团,其中Ra在每次出现时独立地为氢或a)卤素,b)—(CN,c)—NO2,d)氧代,e)—OH,f)═C(Rb)2;g)C1-20烷基,h)C2-20烯基,i)C2-20炔基,j)C1-20烷氧基,k)C1-20烷硫基,l)C1-20卤代烷基,m)—Y—C3-10环烷基,n)—Y—C6-14芳基,o)—Y-3-12成员环杂基,或p)—Y-5-14成员杂芳基,其中每个C1-20烷基,C2-20烯基,C2-20炔基,C3-10环烷基,C6-14芳基或卤代芳基,3-12成员环杂基和5-14成员杂芳基可选地取代1-4个Rb基团;Y在每次出现时独立地为二价的C1-6烷基,二价的C1-6卤代烷基或共价键;R1,R2,R3在每次出现时独立地为H,卤素,CN,C1-30烷基,C2-30烯基,C1-30卤代烷基,C2-30炔基,C1-30烷氧基,C(O)—C1-20烷基,C(O)—OC1-20烷基,Y—C3-10环烷基,—Y-3-12成员环杂基,每个可选地取代1-5个取自卤素,—CN,C1-6烷基,C1-6烷氧基和C1-6卤代烷基的取代基,-L-Ar1,-L-Ar1-—Ar1,-L-Ar1—R4或-L-Ar1—Ar1—R4,并且Y在每次出现时独立地为二价的C1-6烷基,二价的C1-6卤代烷基或共价键;n = 0,1,2;和o = 1-1000。
  • OXAZOLIDONE COMPOUND, PREPARING METHOD AND APPLICATION THEREOF
    申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    公开号:US20150361091A1
    公开(公告)日:2015-12-17
    The present invention relates to the field of a pharmaceutical compound, and more specifically, relates to a new oxazolidone compound, an enantiomer, a diastereoisomer and a raceme thereof, and a mixture thereof, and a pharmaceutically acceptable salt thereof, a preparation method thereof, an application thereof as a bioactive substance in a drug. The compound in the present invention has strong anticoagulant activity, does not affect the activity of thrombin, and can reduce the risk of hemorrhage. A pharmacokinetics experiment shows that the compound in the present invention further has good metabolic characteristics, and has a far better oral bioavailability than a positive contrastive agent rivaroxaban.
    本发明涉及制药化合物领域,更具体地涉及一种新的噁唑烷化合物,其对映异构体、二对映异构体和混合物,以及其药学上可接受的盐、制备方法及其在药物中作为生物活性物质的应用。本发明中的化合物具有强烈的抗凝血活性,不影响凝血酶的活性,并能降低出血风险。药代动力学实验表明,本发明中的化合物还具有良好的代谢特性,并且具有比阳性对照剂利伐沙班更好的口服生物利用度。
  • DERIVES DE N-(ARYLSULFONYL)BETA-AMINOACIDES COMPORTANT UN GROUPE AMINOETHYLE SUBSTITUE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES EN CONTENANT
    申请人:Sanofi-Aventis
    公开号:EP1373233B1
    公开(公告)日:2007-09-05
  • Ink composition for color-memorizing photochromic writing instrument and writing instrument using the same
    申请人:Shibahashi Yutaka
    公开号:US20070082977A1
    公开(公告)日:2007-04-12
    An ink composition for a color-memorizing photochromic writing instrument, which comprises a photochromic agent containing a diarylethene photochromic compound dissolved, dispersed or suspended in a vehicle containing at least a solvent and a binder.
  • METHOD OF LIQUID FUEL DESULFURIZATION
    申请人:ALLIANT TECHSYSTEMS, INC.
    公开号:US20140166539A1
    公开(公告)日:2014-06-19
    Disclosed herein are systems and methods for vortex tube desulfurization of jet fuels. Also disclosed are processes for separation of closely boiling species in a mixture of miscible fluids.
查看更多

同类化合物